Buy Satsuma Pharmaceuticals Inc Stock | STSA Stock Price & Latest News | Public

STSA

Satsuma Pharmaceuticals Inc

$0.00 (0.00%)Today

    About STSA

    Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA. The full company ...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Rating

    What Wall St. analysts suggest for this stock

    1

    Price Targets

    What analysts think this stock will be worth

    $24.44
    current
    $29.67
    average

    Events

    List of events that could affect this stock.

    12May

    Earnings data Q1 2020

    11Aug

    Earnings data Q2 2020

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.47
    -0.7
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.70

    Actual EPS
    Q3 2020

    Stats

    Market Cap$447,77M
    Volume3,3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$36.10
    1 Year Low$8.61
    Open$25.43
    High$25.52
    Low$23.88

    Buy any stock with any amount of money.

    Download the App
    Download the app